{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:25:22Z","timestamp":1778883922027,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jocn.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:06:01Z","timestamp":1669817161000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Non-immune system comorbidity in neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"107","author":[{"given":"Linjun","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichao","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jocn.2022.11.008_b0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"9451","key":"10.1016\/j.jocn.2022.11.008_b0010","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jocn.2022.11.008_b0015","first-page":"46 102515","article-title":"Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder","author":"Cai","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jocn.2022.11.008_b0020","first-page":"14 162","article-title":"Neuromyelitis optica spectrum disorders without and with autoimmune diseases","author":"Zhang","year":"2014","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2022.11.008_b0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"issue":"4","key":"10.1016\/j.jocn.2022.11.008_b0030","first-page":"CR241-6","article-title":"Predictors of mortality among nursing home residents with a diagnosis of Parkinson\u2019s disease","volume":"8","author":"Fernandez","year":"2002","journal-title":"Med Sci Monit"},{"issue":"8","key":"10.1016\/j.jocn.2022.11.008_b0035","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.wnl.0000240129.46080.53","article-title":"Relationship of vascular risk to the progression of Alzheimer disease","volume":"67","author":"Regan","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2022.11.008_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2022.11.008_b0045","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ene.13297","article-title":"Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships","volume":"24","author":"Thormann","year":"2017","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2022.11.008_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.jocn.2022.11.008_b0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.11.008_b0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol"},{"issue":"13","key":"10.1016\/j.jocn.2022.11.008_b0065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.11.008_b0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with Neuromyelitis Optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.jocn.2022.11.008_b0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.jocn.2022.11.008_b0080","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.jocn.2022.11.008_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jocn.2022.11.008_b0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2022.11.008_b0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3343\/alm.2012.32.5.331","article-title":"Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder","volume":"32","author":"Kang","year":"2012","journal-title":"Ann Lab Med"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jocn.2022.11.008_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/PROM.S148387","article-title":"Comorbidity in US patients with multiple sclerosis","volume":"9","author":"Edwards","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.jocn.2022.11.008_b0110","doi-asserted-by":"crossref","first-page":"102685","DOI":"10.1016\/j.msard.2020.102685","article-title":"Frequency of comorbidities in Neuromyelitis Optica spectrum disorder","volume":"48","author":"Barzegar","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"10.1016\/j.jocn.2022.11.008_b0115","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/jnnp-2017-317202","article-title":"Low body mass index can be associated with the risk and poor outcomes of neuromyelitis optica with aquaporin-4 immunoglobulin G in women","volume":"89","author":"Baek","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.jocn.2022.11.008_b0120","doi-asserted-by":"crossref","first-page":"e01350","DOI":"10.1002\/brb3.1350","article-title":"Blood pressure and body fat percent in women with NMOSD","volume":"9","author":"Chen","year":"2019","journal-title":"Brain Behav"},{"issue":"6","key":"10.1016\/j.jocn.2022.11.008_b0125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","article-title":"Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US Department of Defense administrative claims database","volume":"4","author":"Capkun","year":"2015","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.jocn.2022.11.008_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1352458516650512","article-title":"Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course","volume":"23","author":"Conway","year":"2017","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.jocn.2022.11.008_b0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","article-title":"Cumulative impact of comorbidity on quality of life in MS","volume":"125","author":"Marrie","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"10.1016\/j.jocn.2022.11.008_b0140","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458511414041","article-title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","volume":"17","author":"Marrie","year":"2011","journal-title":"Mult Scler"},{"issue":"15","key":"10.1016\/j.jocn.2022.11.008_b0145","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","article-title":"Important causes of visual impairment in the world today","volume":"290","author":"Congdon","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(97)00141-X","article-title":"Normal human aging: factors contributing to cerebral atrophy","volume":"152","author":"Akiyama","year":"1997","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.jocn.2022.11.008_b0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/CON.0000000000000767","article-title":"Ischemic optic neuropathy","volume":"25","author":"Morrow","year":"2009","journal-title":"Continuum (Minneap Minn)"},{"issue":"13","key":"10.1016\/j.jocn.2022.11.008_b0160","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/01.wnl.0000257815.20548.df","article-title":"Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study","volume":"68","author":"Jefferson","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0165","first-page":"40","article-title":"Retinal vein occlusion review","volume":"7","author":"Ip","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0895-4356(98)00124-3","article-title":"Association of comorbidity with disability in older women: the Women\u2019s Health and Aging Study","volume":"52","author":"Fried","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11136-004-0616-2","article-title":"Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning","volume":"14","author":"Rijken","year":"2005","journal-title":"Qual Life Res"},{"issue":"24","key":"10.1016\/j.jocn.2022.11.008_b0180","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2022.11.008_b0185","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-020-09699-2","article-title":"Clinical features and prognosis of patients with late-onset neuromyelitis optica spectrum disorders in a Latin American population","volume":"257","author":"Carnero Contentti","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp-2021-327206","article-title":"Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"93","author":"Camera","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jocn.2022.11.008_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000515555","article-title":"Clinical characteristics of Chinese male patients with aquaporin-4 antibody-positive late-onset neuromyelitis optica spectrum disorder","volume":"28","author":"Liang","year":"2021","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"10.1016\/j.jocn.2022.11.008_b0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison ofdrug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.jocn.2022.11.008_b0205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1352458514564485","article-title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jocn.2022.11.008_b0210","doi-asserted-by":"crossref","first-page":"e0148573","DOI":"10.1371\/journal.pone.0148573","article-title":"Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors","volume":"11","author":"Marck","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2022.11.008_b0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica","volume":"384","author":"Ajmera","year":"2018","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.jocn.2022.11.008_b0220","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood-brain barrier","volume":"32","author":"Rosenberg","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"13","key":"10.1016\/j.jocn.2022.11.008_b0225","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1352458517731914","article-title":"Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"issue":"5","key":"10.1016\/j.jocn.2022.11.008_b0230","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1212\/NXI.0000000000000482","article-title":"Paraneoplastic NMOSD associated with EG junction adenocarcinoma expressing unprotected AQP4","volume":"5","author":"Sudo","year":"2018","journal-title":"Neurol (R) Neuroimmunol Neuroinflammation"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2022.11.008_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2013.07.003","article-title":"Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma","volume":"263","author":"Frasquet","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.jocn.2022.11.008_b0240","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1212\/NXI.0000000000001045","article-title":"Paraneoplastic AQP4-IgG-seropositive neuromyelitis optica spectrum disorder associated with teratoma: a case report and literature review","volume":"8","author":"Ikeguchi","year":"2021","journal-title":"Neurol (R) Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jocn.2022.11.008_b0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-005-0069-1","article-title":"Diabetes and brain aging: epidemiologic evidence","volume":"5","author":"Launer","year":"2005","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.jocn.2022.11.008_b0250","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","article-title":"Effect of comorbidity on mortality in multiple sclerosis","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.jocn.2022.11.008_b0255","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:31:24Z","timestamp":1760823084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":51,"alternative-id":["S0967586822004593"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.11.008","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-immune system comorbidity in neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}